Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat.
about
Potential therapeutic effects of neurotrophins for acute and chronic neurological diseasesIschemic stroke and repair: current trends in research and tissue engineering treatmentsGrowth factors for the treatment of ischemic brain injury (growth factor treatment)Localized cell and drug delivery for auditory prostheses.Development of neuropeptide drugs that cross the blood-brain barrier.Astrocyte-derived growth factors and estrogen neuroprotection: role of transforming growth factor-α in estrogen-induced upregulation of glutamate transporters in astrocytesReperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection.Mature and precursor brain-derived neurotrophic factor have individual roles in the mouse olfactory bulbGenetic variation at the BDNF locus: evidence for association with long-term outcome after ischemic strokeAntidepressant-like effects of erythropoietin: a focus on behavioural and hippocampal processes.Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia.Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortexGrowth factors and stroke.Effect of exercise-induced neurogenesis on cognitive function deficit in a rat model of vascular dementia.An immortalized rat ventral mesencephalic cell line, RTC4, is protective in a rodent model of strokeI.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult ratPhosphoinositide 3-kinase enhancer (PIKE) in the brain: is it simply a phosphoinositide 3-kinase/Akt enhancer?Role of signal transducer and activator of transcription 3 in neuronal survival and regenerationBrain plasticity and genetic factors.From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)VGF (TLQP-62)-induced neurogenesis targets early phase neural progenitor cells in the adult hippocampus and requires glutamate and BDNF signaling.Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model.Blood-brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses.Brain-derived neurotrophic factor-transfected and nontransfected 3T3 fibroblasts enhance migratory neuroblasts and functional restoration in mice with intracerebral hemorrhage.Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways.Ultrastructural and MRI study of the substantia nigra evolving exofocal post-ischemic neuronal death in the rat.Effects of brain-derived neurotrophic factor (BDNF) on compression-induced spinal cord injury: BDNF attenuates down-regulation of superoxide dismutase expression and promotes up-regulation of myelin basic protein expression.Intravenous administration of DPSCs and BDNF improves neurological performance in rats with focal cerebral ischemia.Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence.
P2860
Q26827281-14845D9A-A7D8-47AD-9481-F54C72C731E2Q26851602-F59BA6E1-796A-4A35-B8A9-9ACF58830876Q27005953-162DE078-95F2-4B20-847C-0E37D74DF015Q30475885-A8FA3C7C-A209-4A0D-B73B-2BF5DAF20196Q33569277-174F018A-7578-4C64-960F-B4A4DC0C0B32Q33693204-74914098-DC50-4C63-896E-A74BF68DCF34Q33879330-29C725CE-1BC3-4A79-BAD1-3A2E46EA4AF7Q34171537-74896310-A2FD-4AFB-ABAD-2624CF807692Q34627311-1C1D441C-5708-43EE-A668-5023E5EF59EBQ34982719-64D00FE0-713B-4C96-810D-54CFF1404852Q36195042-C551B583-D171-48F5-B27F-E73C22C6E2E4Q36551237-380E7AF6-9996-4D32-8AAD-9C387F6E80C9Q36608807-846C16DB-2D15-4C27-9EEC-5708CCF22909Q36722254-3E2307B4-5821-4422-B360-4C55F142F9FDQ36808331-CECAB345-0064-48A2-97F3-880ACF250F09Q37020088-786EB66E-19A5-421A-B92D-B80AF25BE788Q37139942-32DFF372-ECA5-449E-AF04-85F5AB65B349Q37190629-800F8606-11E0-4A73-9599-E14EED24B81EQ37594329-BB616CE8-A084-4CB1-A4E3-186C6F2EEA46Q38168376-7E8EC35F-CC64-4F12-BF36-66F6B18D3FABQ39002821-D6185538-C82D-4DC9-80C5-BBAABE088AFAQ41827325-B7866BBD-8B69-484F-9F25-E133F690B8F2Q41973261-63B2588B-FCB1-4739-A476-194D9DB2F8FDQ42828792-1E65C733-2678-4C26-A025-FE8ED2216CF1Q46500200-D28A1879-BCC0-4C5B-9FEA-68D3CC825922Q48454118-7AE87E40-7E84-4752-9F8E-E8BE9268E638Q48684233-A7E75B63-D07C-4E64-8E5C-D7EB205E6645Q54095845-AF870D8D-929C-473E-87A9-BB6B268FCC66Q55092215-8E0938DF-A148-4705-A96A-C2C8EC4DA054
P2860
Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Post-occlusion treatment with ...... middle cerebral artery in rat.
@en
Post-occlusion treatment with ...... middle cerebral artery in rat.
@nl
type
label
Post-occlusion treatment with ...... middle cerebral artery in rat.
@en
Post-occlusion treatment with ...... middle cerebral artery in rat.
@nl
prefLabel
Post-occlusion treatment with ...... middle cerebral artery in rat.
@en
Post-occlusion treatment with ...... middle cerebral artery in rat.
@nl
P2093
P356
P1476
Post-occlusion treatment with ...... middle cerebral artery in rat.
@en
P2093
Hossmann KA
Lindholm D
Wiessner C
Yamashita K
P2888
P304
P356
10.1023/A:1022322025000
P577
1997-12-01T00:00:00Z
P6179
1004108048